$CPAY

Corpay (CPAY) Stock Gets Fair Value Boost After Q2 Guidance And Analyst Target Increases

Simply Wall St reports Corpay (CPAY) fair value increased from $395.14 to $438.50 (about 11%) after Q2 results, raised 2026 guidance, and analyst updates. Multiple firms lifted targets into the low to mid $400s, including Baird to $475 and Morgan Stanley to $455. Key model inputs changed: revenue growth and net margin assumptions declined while future P/E rose.

Original reporting
Published Aug 9, 2026, 11:14 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 12:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Corpay (CPAY) Stock Gets Fair Value Boost After Q2 Guidance And Analyst Target Increases — source image
Decision brief

The 30-second read

$CPAYBullishLow
01

Why it matters

It frames an 11% fair value increase to $438.50, attributing the shift to raised 2026 guidance and Q2 performance, while also noting that some analysts remain more cautious (Sector Perform).

02

Market read

Valuation and analyst-target revisions after Q2 guidance can influence positioning, but the article does not introduce a new primary disclosure beyond what is already referenced as Q2/raised guidance.

03

What to watch

The article flags risks (compliance/cybersecurity costs, competition, tech and M&A execution, Lodging underperformance) but provides no new quantitative risk update, so traders should not over-weight the valuation uplift versus execution risk.

Relevance 4/10Novelty 4/10Timing: today’s read is about updated fair value and analyst target clustering after Q2

Background

The piece summarizes Simply Wall St’s updated valuation model for Corpay and the Street’s post-Q2 analyst target revisions.

Company-level read

Ticker impact

$CPAYBullishMedium confidence
Context

Simply Wall St reports Corpay’s fair value estimate rising from $395.14 to $438.50 after Q2 guidance and raised 2026 guidance.

Expected impact

Near-term price impact is likely limited because the piece is primarily a model/analyst-target recap rather than a fresh disclosure; any impact would be sentiment-driven around the already-known guidance.

Evidence & confidence

It cites updated fair value assumptions (growth, margins, P/E, discount rate) and mentions raised guidance, but it does not provide a new primary disclosure (no earnings/guidance numbers newly printed in the text, no filing, no deal).

Market effects

Could modestly support sentiment for B2B/cross-border payments peers if investors view guidance durability and corporate payments growth as improving.

No specific regional catalyst beyond general US-listed payments sentiment.

Limited, as the update is valuation/analyst-target oriented with no new global policy or cross-border regulatory event described.

Counterpoint

The fair value increase is driven by model inputs (growth, margins, discount rate) and analyst-target clustering, which can reverse if organic growth or corporate payments growth under-deliver.

Key entities

  • Corpay

    US-listed payments company whose fair value estimate and analyst targets are discussed after Q2 guidance and raised 2026 guidance.

  • Baird

    Raised price target into the $400s range (cited as $475).

  • Keefe Bruyette

    Raised price target into the $400s range (cited as $470).

  • Wolfe Research

    Raised price target into the $400s range (cited as $450).

  • Oppenheimer

    Raised price target into the $400s range (cited as $454) and highlights Q2 organic revenue growth and raised guidance.

Related articles

$CPAYMed

Corpay (CPAY) Just Posted A Record Quarter, So Why The Caution?

Corpay (NYSE:CPAY) reported Q2 2026 revenue of $1.34 billion, up 21% year over year and $45 million above expectations, with cash EPS of $7.00, up 36%. The company raised full-year guidance to $5.31 billion revenue and $27.35 cash EPS midpoint, citing growth in Corporate and Vehicle Payments, plus Alpha and Avid contributions, while noting a $100 million FTC-related charge and an Epics divestiture.

$CPAYMedAI 8/10

Corpay (CPAY) Q2 2026 Earnings Call Transcript

Corpay (NYSE:CPAY) reported Q2 2026 revenues of $1.34B, up 21%, and adjusted net income per diluted share of $7.00, up 36% year over year. Management guided FY2026 revenue to $5.29B-$5.33B and adjusted EPS to $27.15-$27.55, plus FCF of about $1.8B. The quarter included a $100M FTC settlement charge and $321M in share repurchases.

$CPAYHighAI 9/10

Corpay Q2 Earnings Call Highlights

Corpay (NYSE:CPAY) raised full-year revenue guidance to $5.31B at the midpoint (+17% vs 2025) and adjusted EPS to $27.35 (+28%). Q2 results included a $45M revenue beat; guidance reflects improved macro and momentum, partly offset by an epyx sale expected to close in fall. Q3 revenue midpoint is $1.355B, adjusted EPS $7.15.

$CPAYMedAI 8/10

Corpay: Q2 Earnings Snapshot

Corpay, Inc. (CPAY) reported Q2 net income of $248.3 million, or $3.70 per share. Adjusted earnings were $7.00 per share versus a Zacks estimate of $6.60. Revenue was $1.34 billion versus $1.31 billion expected. Corpay forecast full-year earnings of $27.15 to $27.55 per share and revenue of $5.29 to $5.33 billion.